Literature DB >> 29962285

Surgical Confirmation of Incomplete Treatment for Primary Papillary Thyroid Carcinoma by Percutaneous Thermal Ablation: A Retrospective Case Review and Literature Review.

Ben Ma1,2, Wenjun Wei1,2, Weibo Xu1,2, Yu Wang1,2, Haixia Guan3, Jingbin Fan4, Zhihong Zhao5, Duo Wen1,2, Shuwen Yang1,2, Yulong Wang1,2, Bin Chang1,6, Qinghai Ji1,2.   

Abstract

BACKGROUND: Recently, thermal ablation has been proposed for treating primary papillary thyroid carcinoma (PTC), triggering an extensive debate. This study aimed to analyze surgical outcomes of post-ablation cases to investigate the effectiveness and safety of thermal ablation in primary PTC.
METHODS: Primary PTC patients treated with thermal ablation were retrospectively searched for from the authors' medical record database prior to August 2017. The surgical patients met the following criteria: (i) primary PTC treated with thermal ablation, (ii) findings suspicious for malignancy of the post-ablation lesions on ultrasound or malignancy confirmed by cytology, or with clinical evidence of cervical lymph node metastasis (LNM), (iii) written informed consent for surgery, (iv) preference for definite diagnosis of the post-ablation lesions for the patients without evidence for malignant findings, and (v) tolerance of a thyroidectomy and without severe illness. Moreover, a systematic review of the literature was made to analyze relevant cases.
RESULTS: Twelve patients with an average age of 41.0 ± 13.6 years constituted the Fudan University Shanghai Cancer Center cohort in this study. Twenty-two foci with a mean size of 1.3 ± 0.7 cm were ablated percutaneously under ultrasound guidance. Residual PTCs were confirmed in all cases by histopathology, and LNM was present in 66.7% (8/12) of the patients. Intraoperatively, adhesion of the post-ablation lesions with the strap muscles was observed in six cases. Strap muscles were found to be cauterized in five cases, and notably the recurrent laryngeal nerve was involved in one case. Furthermore, seven relevant studies from Korea, Italy, and China were retrospectively reviewed, and incomplete ablation of primary PTC and omission of LNM by thermal ablation were observed frequently.
CONCLUSIONS: Surgical therapy demonstrated incomplete ablation of primary PTC and omission of LNM by thermal ablation in this cohort of patients. Thermal ablation should be recommended with caution as treatment of operable patients with primary PTC.

Entities:  

Keywords:  LNM; incomplete treatment; papillary thyroid carcinoma; surgery; thermal ablation

Mesh:

Year:  2018        PMID: 29962285     DOI: 10.1089/thy.2017.0558

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  14 in total

1.  Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysis.

Authors:  Se Jin Cho; Sun Mi Baek; Dong Gyu Na; Kang Dae Lee; Young Kee Shong; Jung Hwan Baek
Journal:  Eur Radiol       Date:  2021-03-13       Impact factor: 5.315

2.  Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.

Authors:  Lin Yan; Xinyang Li; Yingying Li; Jing Xiao; Mingbo Zhang; Yukun Luo
Journal:  Eur Radiol       Date:  2022-07-27       Impact factor: 7.034

Review 3.  Efficacy and safety of radiofrequency ablation in the treatment of low-risk papillary thyroid carcinoma: a review.

Authors:  Spyridon Ntelis; Dimitrios Linos
Journal:  Hormones (Athens)       Date:  2021-04-06       Impact factor: 2.885

4.  Radiofrequency ablation and thyroid nodules: updated systematic review.

Authors:  Haris Muhammad; Prasanna Santhanam; Jonathon O Russell
Journal:  Endocrine       Date:  2021-01-15       Impact factor: 3.633

5.  Inhibitory effects of miR‑26b‑5p on thyroid cancer.

Authors:  Aiya Zhou; Gengyu Chen; Xiankui Cheng; Chi Zhang; Hao Xu; Ming Qi; Xiao Chen; Tiantian Wang; Leping Li
Journal:  Mol Med Rep       Date:  2019-05-31       Impact factor: 2.952

6.  US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population.

Authors:  Hyun Kyung Lim; Se Jin Cho; Jung Hwan Baek; Kang Dae Lee; Chang Woo Son; Jung Min Son; Seon Mi Baek
Journal:  Korean J Radiol       Date:  2019-12       Impact factor: 3.500

7.  Surgery After Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China.

Authors:  Wei Sun; Hao Zhang; Liang He; Ting Zhang; Zhihong Wang; Wenwu Dong; Yingling Jiang
Journal:  Med Sci Monit       Date:  2020-11-22

8.  Residual tumor and central lymph node metastasis after thermal ablation of papillary thyroid carcinoma: A case report and review of literature.

Authors:  Yu Hua; Jia-Wen Yang; Liu He; Hua Xu; Hai-Zhong Huo; Chen-Fang Zhu
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

Review 9.  Thermal Ablation for Papillary Thyroid Microcarcinoma: How Far We Have Come?

Authors:  Yu Min; Xing Wang; Hang Chen; Jialin Chen; Ke Xiang; Guobing Yin
Journal:  Cancer Manag Res       Date:  2020-12-24       Impact factor: 3.989

10.  miRNA-144-5p/ITGA3 Suppressed the Tumor-Promoting Behaviors of Thyroid Cancer Cells by Downregulating ITGA3.

Authors:  Jizong Zhang; Yan Zhong; Yiming Sang; Guanghui Ren
Journal:  Comput Math Methods Med       Date:  2021-12-13       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.